Figure 2 shows the chemical structure of antibiotics that have been approved or are currently under development for the treatment of serious MRSA infections.

Most cases of MRSA respond to antibiotic treatment. However, individuals who have a compromised immune system are at increased risk of systemic MRSA and are more likely to develop potentially life ...

Healthcare exposure within 90 days and prior antibiotic exposure were significantly more prevalent in the MRSA than the non ... for the entire treatment duration; 18 patients switched from ...

This means that only certain antibiotics will work to fight MRSA. One common treatment for MRSA is a medication called ...

it will be the first antibiotic in the beta-lactam class to or the treatment of SAB S. aureus, including hard-to-treat infections caused by methicillin-resistant strains (MRSA), said Basilea.

Zevtera® has gained U.S. Food and Drug Administration (FDA) approval in April 2024 for three specific indications, including the treatment ... approved MRSA-targeting cephalosporin antibiotic ...

Public health officials are concerned that we could move back into a situation like that of the early 20th century, before ...

Antibiotic treatment during an influenza infection actually impaired the body’s efforts to clear bacteria rather than helping the body heal.

is to compare these different antibiotics in real patients in order to identify an optimal treatment. The study revealed several potential risk factors for community-associated MRSA. Patients with ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on ...